Crescent Biopharma, Inc.CBIONASDAQ

Revenue (LTM)

$11M

Net Income (LTM)

$-150M

-109.8% YoY

Free Cash Flow

$-72M

Revenue CAGR (5Y)

+1.3%

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	1	0↓93.5%	0↓86.7%	0	11
Gross Profit	1	0↓93.5%	0↓86.7%	-0↓451.7%	11↑30690.8%
Operating Income	-63	-47↑25.3%	-39↑17.1%	-69↓75.1%	-153↓122.0%
Net Income	-63	-47↑26.4%	-37↑21.0%	-71↓93.7%	-150↓109.8%
EBITDA	-63	-47↑25.3%	-39↑17.1%	0	-150
EPS Diluted	-1.23	-0.89↑27.6%	-0.58↑34.8%	-0.59↓1.7%	0.02↑103.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	90	48↓47.0%	42↓12.7%	35↓16.8%	213↑513.2%
Total Current Assets	91	51↓44.1%	44↓13.7%	35↓20.5%	237↑580.0%
Total Assets	94	52↓45.1%	45↓12.5%	36↓21.4%	240↑574.7%
Total Current Liabilities	12	9↓24.9%	7↓23.0%	10↑40.7%	36↑275.2%
Total Liabilities	13	9↓30.3%	7↓22.3%	51↑640.3%	37↓27.0%
Total Equity	82	43↓47.4%	38↓10.5%	5↓86.2%	203↑3720.6%
Total Debt	2	1↓52.2%	1↓12.0%	37↑4536.6%	2↓95.6%
Net Debt	-88	-47↑46.8%	-41↑12.7%	3↑106.6%	-212↓7889.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-57	-46↑19.2%	-35↑24.9%	-31↑10.8%	-72↓130.0%
Capital Expenditure	-0	-0↓463.4%	-0↑74.6%	-0↑53.4%	-1↓9115.8%
Free Cash Flow	-58	-47↑19.1%	-35↑25.0%	-31↑10.9%	-72↓132.9%
Stock-Based Comp	6	4↓36.6%	4↓7.7%	5↑34.1%	13↑178.7%
Net Change in Cash	-47	-42↑9.4%	-6↑85.7%	-31↓411.2%	179↑674.6%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance